Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs Healthicare

Fierce Health
Graded #411

Lower grade

vs+8.899999999999999
Healthicare
Graded #221

Higher grade

The verdict

Healthicare takes it — 65.5/100 to 56.6/100.

Healthicare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthicare +25
33
58
Dose & formulationHealthicare +11
77
88
Clinical oversightHealthicare +9
62
71
Labs & monitoringHealthicare +1
52
53
FulfillmentFierce Health +13
75
62
Contract termsEven
47
47
Fierce Health · left barHealthicare · right bar

The numbers

MetricFierce HealthHealthicare
WeighScore56.6/10065.5/100
GradeCC
Scorecard rank#411#221
Semaglutide$297/mo (3-month plan, compounded)$174/mo (compounded)
Tirzepatide$497/mo (3-month plan, compounded)$264/mo (compounded)
Coverage30 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Fierce Health

Graded #411 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

Where it loses points

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Healthicare

Graded #221 · C

Strengths

  • Both compounded and full brand-name menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
  • Pharmacy partner named publicly: Jungle Jim's Pharmacy (F&F Pharmacies Inc.), Fairfield, OH
  • Clinical lead named publicly: Dr. Jonah Mink, Beluga Health
  • Compounded semaglutide from $147.90/mo on the 3-month plan ($174/mo billed monthly) — lower end of the segment

Where it loses points

  • Not available in several states including CA, NV, NJ, NC, TX, MA — verify your state first
  • Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above cash retail; value is on the compounded tier
  • Footer references 'Sunshine Health Studios Inc.' — relationship to the domain owner is unclear

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard